HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc N Potenza Selected Research

Oxytocin (Pitocin)

1/2017Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc N Potenza Research Topics

Disease

50Gambling (Pathological Gambling)
04/2024 - 01/2003
26Substance-Related Disorders (Drug Abuse)
04/2024 - 01/2009
14Cocaine-Related Disorders (Cocaine Addiction)
01/2019 - 03/2006
11Alcoholism (Alcohol Abuse)
04/2024 - 11/2008
9Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
05/2013 - 07/2006
8Obesity
01/2022 - 02/2010
8Parkinson Disease (Parkinson's Disease)
03/2016 - 07/2006
5Mental Disorders (Mental Disorder)
01/2023 - 03/2004
5COVID-19
01/2021 - 01/2020
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2020 - 01/2009
4Tobacco Use Disorder (Nicotine Dependence)
01/2024 - 11/2013
4Food Addiction
12/2023 - 04/2015
4Wounds and Injuries (Trauma)
12/2020 - 08/2014
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2024 - 06/2020
3Mood Disorders (Mood Disorder)
01/2023 - 07/2019
3Pain (Aches)
01/2021 - 01/2017
2Opioid-Related Disorders (Opiate Addiction)
08/2023 - 01/2022
2Anxiety Disorders (Anxiety Disorder)
05/2023 - 06/2014
2Binge-Eating Disorder (Binge Eating Disorder)
02/2023 - 01/2021
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2022 - 01/2019
2Bulimia (Binge Eating)
04/2016 - 03/2014
1Hypertension (High Blood Pressure)
03/2022
1Heart Diseases (Heart Disease)
03/2022
1Epilepsy (Aura)
01/2022
1Multiple Sclerosis
01/2022
1Major Depressive Disorder (Major Depressive Disorders)
09/2021
1Genetic Risk Score
01/2021
1Marijuana Use
12/2020
1Medically Unexplained Symptoms
11/2020
1Disease Progression
10/2017

Drug/Important Bio-Agent (IBA)

32Cocaine (Cocaine HCl)IBA
04/2024 - 10/2004
10Dopamine (Intropin)FDA LinkGeneric
01/2021 - 12/2007
8Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 05/2008
8Dopamine Agonists (Dopamine Agonist)IBA
03/2016 - 07/2006
5Immunoglobulin D (IgD)IBA
02/2023 - 01/2017
5Heroin (Diamorphine)IBA
12/2022 - 02/2010
5CannabinoidsIBA
01/2022 - 12/2012
5Narcotic Antagonists (Opioid Antagonists)IBA
02/2020 - 01/2003
5Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 01/2004
4Methamphetamine (Desoxyn)FDA LinkGeneric
12/2023 - 03/2019
4Methadone (Dolophine)FDA LinkGeneric
01/2021 - 09/2016
4Opioid Analgesics (Opioids)IBA
01/2021 - 08/2013
4Naltrexone (ReVia)FDA LinkGeneric
02/2020 - 11/2008
4NicotineFDA Link
01/2014 - 03/2009
3Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
05/2023 - 01/2003
3Amphetamine (Amfetamine)FDA LinkGeneric
12/2022 - 11/2020
3Illicit Drugs (Recreational Drugs)IBA
01/2021 - 11/2013
3SmokeIBA
11/2020 - 06/2008
3Paroxetine (Paxil)FDA LinkGeneric
09/2016 - 07/2003
3nalmefene (Revex)FDA Link
10/2010 - 02/2006
2Indicators and Reagents (Reagents)IBA
11/2023 - 09/2016
2Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2023 - 08/2013
2Biomarkers (Surrogate Marker)IBA
02/2023 - 01/2018
2Insulin (Novolin)FDA Link
03/2022 - 02/2013
2amsonic acid (DAS)IBA
01/2020 - 03/2016
2Crack CocaineIBA
03/2019 - 01/2009
2Disulfiram (Antabuse)FDA Link
11/2017 - 01/2017
2Opiate AlkaloidsIBA
01/2017 - 11/2008
2Caffeine (No Doz)FDA LinkGeneric
12/2015 - 01/2014
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
10/2014 - 12/2012
2Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
02/2014 - 11/2013
2Glutamic Acid (Glutamate)FDA Link
08/2013 - 12/2010
25-HT1B Serotonin ReceptorIBA
03/2013 - 05/2010
2Antipsychotic Agents (Antipsychotics)IBA
01/2004 - 01/2003
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
04/2024
1salicylhydroxamic acid (SHAM)IBA
01/2024
1Hormones (Hormone)IBA
12/2023
1LeptinIBA
12/2023
1glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
11/2023
1anandamide (arachidonylethanolamide)IBA
11/2023
1mesoglycanIBA
06/2023
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
05/2023
1OrexinsIBA
01/2023
1NeuropeptidesIBA
01/2023
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
04/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1BaclofenFDA LinkGeneric
01/2022
1Modafinil (Provigil)FDA Link
01/2022
1Hallucinogens (Psychedelics)IBA
01/2022
1KetamineFDA LinkGeneric
01/2022
1saracatinibIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
01/2022
1Dronabinol (THC)FDA LinkGeneric
01/2022
1SuspensionsIBA
01/2021
1COVID-19 VaccinesIBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2021
1naxagolideIBA
01/2021
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2021
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
03/2019
1BenzodiazepinesIBA
01/2019
1SugarsIBA
01/2017
1Oxytocin (Pitocin)FDA LinkGeneric
01/2017
1CarbohydratesIBA
01/2017

Therapy/Procedure

15Therapeutics
01/2021 - 12/2007
9Drug Therapy (Chemotherapy)
05/2023 - 07/2006
2Behavior Control
01/2024 - 02/2013
2Duration of Therapy
01/2021 - 01/2003
2Aftercare (After-Treatment)
01/2014 - 05/2012
1Transcranial Direct Current Stimulation
01/2021